title: [Immune reactions after DMEK, DSAEK and DALK].
abstract: OBJECTIVE
  The aim of this study is to describe incidence, diagnosis and therapy for endothelial immune reactions after modern lamellar corneal transplantat surgery (DMEK, DSAEK, DALK).
  
  
  METHODS
  A PubMed-based literature review and our own clinical and experimental data are evaluated.
  
  
  RESULTS
  There is no longer an endothelial immune reaction after DALK for keratoconus. DMEK significantly reduces the risk for endothelial immune reactions after surgery for Fuchs dystrophy.
  
  
  CONCLUSIONS
  Modern lamellar corneal transplant techniques such as DALK and DMEK have nearly abolished the risk for endothelial immune reactions in the avascular recipient bed.
authors: Zentrum für Augenheilkunde, Universität zu Köln. Kerpener Strasse 62, Koln.
authors: P
authors: P
authors: Steven
authors: D
authors: D
authors: Hos
authors: L M
authors: LM
authors: Heindl
authors: F
authors: F
authors: Bock
authors: C
authors: C
authors: Cursiefen
mesh_terms: D015897:Comorbidity; D003316:Corneal Diseases / Q000453:epidemiology / Q000276:immunology* / Q000601:surgery*; D057111:Descemet Stripping Endothelial Keratoplasty / Q000706:statistics & numerical data*; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology*; D006801:Humans; D007154:Immune System Diseases / Q000453:epidemiology / Q000276:immunology*; D011183:Postoperative Complications / Q000453:epidemiology* / Q000276:immunology*; D015995:Prevalence; D012307:Risk Factors